Pall launches PallSep Biotech filtration system

Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids. The new system utilizes vibrating membrane filtration (VMF) technology and encapsulated hydrophilic polyethersulfone membrane filter modules. This unique combination reduces the accumulation of retained species on the membrane surface which allows for increased transmission of the target molecule.

“The new PallSep Biotech system expands processing options by allowing users to combine different process steps such as harvest and clarification within the same system, thus simplifying the process design”

The VMF principle is based on the rapid oscillation of porous membrane plates within a process feed stream to create shear at the membrane surface. The generated shear forces are limited to a narrow portion of the flow channel, reducing the amount of process fluid exposed to the shear. The cross flow requirements are much lower with the PallSep Biotech system than with other tangential flow filtration (TFF) technologies. This creates gentle processing and good product transmission.

The PallSep Biotech system supports the production of high value products like therapeutic vaccines and antigen extracts. It permits the concentration, clarification and purification of feed streams with high levels of biomass particulates and viscosity, along with difficult-to-filter solutions such as fermentation broths and lysates.

“The new PallSep Biotech system expands processing options by allowing users to combine different process steps such as harvest and clarification within the same system, thus simplifying the process design,” said Nathalie Pathier, TFF product manager, Pall Life Sciences. “The stable permeate flow and improved protein transmission we can achieve with this technology contribute to better process economics.”

The encapsulated 0.2 µm polyethersulfone membrane filter modules, available in filter areas of 0.2, 1 and 5 m2, offer flexibility for scale up and scale down of processes. Typical batch sizes range from a few liters to 500 liters, depending on the process application.

Custom designed for specific requirements, the PallSep Biotech system can be operated manually or within an automated process. It includes all valves, pumps, sensors, vessel and piping elements in a process system. GMP requirements for biopharmaceutical processes are met without compromising ease of use, flexibility, cleanability, safety or operating costs.

SOURCE Pall Corporation

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Pall Corporation. (2010, February 03). Pall launches PallSep Biotech filtration system. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20100203/Pall-launches-PallSep-Biotech-filtration-system.aspx.

  • MLA

    Pall Corporation. "Pall launches PallSep Biotech filtration system". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20100203/Pall-launches-PallSep-Biotech-filtration-system.aspx>.

  • Chicago

    Pall Corporation. "Pall launches PallSep Biotech filtration system". News-Medical. https://www.news-medical.net/news/20100203/Pall-launches-PallSep-Biotech-filtration-system.aspx. (accessed November 22, 2024).

  • Harvard

    Pall Corporation. 2010. Pall launches PallSep Biotech filtration system. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20100203/Pall-launches-PallSep-Biotech-filtration-system.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pall first quarter 2013 sales decrease 3.6% to $627.6 million